Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients

Publisher’s Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may.

Bibliographic Details
Authors: Oliveira, Lucas Barbosa, Mwangi, Victor Irungu, Sartim, Marco Aurélio, Delafiori, Jeany, Sales, Geovana Manzan, Oliveira, Arthur Noin de, Busanello, Estela Natacha Brandt, Val, Fernando Fonseca de Almeida e, Xavier, Mariana Simão, Costa, Fábio Trindade, Baía-Da-Silva, Djane Clarys, Sampaio, Vanderson de Souza, Lacerda, Marcus Vinícius Guimarães de, Monteiro, Wuelton Marcelo, Catharino, Rodrigo Ramos, Melo, Gisely Cardoso de
Format: article
Status:Published version
Publication Date:2022
Country:Brasil
Institution:Fundação Oswaldo Cruz (FIOCRUZ)
Repository:Repositório Institucional da FIOCRUZ (ARCA)
Language:English
OAI Identifier:oai:arca.fiocruz.br:icict/63172
Online Access:https://arca.fiocruz.br/handle/icict/63172
Access Level:Open access
Keyword:Metabolomics
Mass spectrometry
COVID-19
SARS-CoV-2
Metabolites
Prognosis
Description
Summary:Publisher’s Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may.

Similar Items